This webinar will discuss the rationale behind the use of sodium glucose cotransporter-2 inhibitors (SGLT2)i for the management of equine insulin dysregulation that is refractory to management with dietary and exercise changes. We will discuss how these drugs work, the evidence for their use in horses and the potential side effects that need to be considered.

Why do this course?
This webinar is aimed at vets who regularly see horses with insulin dysregulation in association with either equine metabolic syndrome (EMS) or pituitary pars intermedia dysfunction (PPID) and wonder when to suggest pharmacological treatment with a gliflozin. Delegates will learn how these drugs work, which cases they might be suitable for and the possible associated side effects that need to be monitored for.   

Members of the BVA Young Vets Network receive a 50% discount on our recorded webinars (subject to availability – ten discounted places available per webinar per year).

Please note: Our anytime Recorded Webinars and Recorded Webinar Plus CPD are regularly reviewed to ensure they are still providing the most up-to-date information. Please therefore activate the webinar within 3 months of purchase as we cannot guarantee availability after this time period. Any recorded webinars that are removed from sale during the 3 month time period we will offer a free replacement.